ZVRA
ZEVRA THERAPEUTICS, INC.
ZEVRA THERAPEUTICS, INC. (ZVRA) has 9 SEC Form 4 filings (19 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Jun 23, 2026.
The most active filer is Chief Legal & Compliance Thompson Rahsaan with 3 filings. Insiders have net sold $1.6M over the trailing 6 months.
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$1.6M
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Market Cap
$702.3M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Legal & Compliance | Sale | 34,557 | $438K | Jun 23 | SEC ↗ | |
Thompson RahsaanFirst in 3 months | Chief Legal & Compliance | Sale | 1,794 | $20K | May 13 | SEC ↗ |
| President and CEO | Sale | 14,625 | $125K | Feb 10 | SEC ↗ | |
Quartel Adrian WFirst filing | Chief Medical Officer | Sale | 4,533 | $40K | Feb 2 | SEC ↗ |
Schafer JoshuaFirst filing | CCO | Sale | 3,375 | $30K | Feb 2 | SEC ↗ |
McFarlane Neil F.First filing | President and CEO | Sale | 91,000 | $853K | Feb 2 | SEC ↗ |
Thompson RahsaanFirst filing | Chief Legal & Compliance | Sale | 4,080 | $36K | Feb 2 | SEC ↗ |
Sangiovanni Timothy J.First filing | SVP, Finance & Corp Controller | Sale | 1,750 | $15K | Feb 2 | SEC ↗ |
Related companies
ZEVRA THERAPEUTICS, INC. is in the Healthcare sector.